Skip to main content

Mirapex News

FDA Medwatch Alert: Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure

ISSUE: FDA notified healthcare profesionals about a possible increased risk of heart failure with Mirapex (pramipexole). Results of recent studies suggest a potential risk of heart failure that needs...

Once-Daily Mirapex ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease

RIDGEFIELD, Conn., March 23 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily Mirapex ER...

FDA Approves Once-Daily Mirapex ER for the Treatment of Early Parkinson's Disease

RIDGEFIELD, Conn., Feb. 22 /PRNewswire/ – Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER (pramipexole...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Restless Legs Syndrome, Periodic Limb Movement Disorder, Parkinson's Disease

Mirapex patient information at Drugs.com